EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively. It contains Evogliptin 5 mg and Metformin Hydrochloride 500 mg (sustained release). Evogliptin helps increase insulin release and control post-meal sugar levels, while Metformin reduces glucose production and improves insulin sensitivity. This dual action helps maintain stable blood sugar levels throughout the day when combined with proper diet and exercise.
Related products
SITPIN D 10/100
Composition: Sitagliptin 100 mg + Dapagliflozin 10 mg. View SITPIN D 10/100 details or enquire...
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
CARBOSTOP 50
CARBOSTOP 50 Tablet is a combination medicine used for managing type 2 diabetes effectively. It...
GLIDA 2
Composition : glimepiride 40 mg
